Gevo EVP Sells $4,482 in Stock (GEVO)
Gevo (NASDAQ:GEVO) EVP Brett Lund sold 4,718 shares of Gevo stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $0.95, for a total value of $4,482.10. Following the completion of the transaction, the executive vice president now directly owns 115,473 shares of the company’s stock, valued at approximately $109,699. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Gevo (NASDAQ:GEVO) traded down 0.93% during mid-day trading on Thursday, hitting $0.9114. 173,630 shares of the company’s stock traded hands. Gevo has a 1-year low of $0.73 and a 1-year high of $2.30. The stock has a 50-day moving average of $0.94 and a 200-day moving average of $1.20. The company’s market cap is $61.8 million.
Gevo (NASDAQ:GEVO) last released its earnings data on Wednesday, May 14th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03. The company had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.70 million. During the same quarter in the previous year, the company posted ($0.45) earnings per share. The company’s revenue for the quarter was down 74.3% on a year-over-year basis. Analysts expect that Gevo will post $-0.67 EPS for the current fiscal year.
A number of research firms have recently commented on GEVO. Analysts at Cowen and Company cut their price target on shares of Gevo to $1.00 in a research note on Friday, May 16th. Separately, analysts at Zacks downgraded shares of Gevo from an “outperform” rating to a “neutral” rating in a research note on Thursday, May 8th. They now have a $1.30 price target on the stock. Finally, analysts at Zacks upgraded shares of Gevo from a “neutral” rating to an “outperform” rating in a research note on Wednesday, April 9th. They now have a $1.50 price target on the stock.
Gevo, Inc, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.